Herbal Medicine Compliance

Herbal Medicine Compliance

Full regulatory workflow for botanical and herbal medicinal products. Sits between pharmaceutical, food supplement, and traditional medicine frameworks — wrong classification adds 3-7 years to launch.

Decision Flow

digraph {
  rankdir=TB; node [shape=box style=rounded fontsize=10];
  classify [label="1. Classify product:\nmedicine / supplement / cosmetic\n/ TCM / Kampo / food"];
  plant [label="2. Per-plant check:\nbanned, restricted, monograph,\nnovel food status"];
  framework [label="3. Pick framework:\nTHMPD 2004/24, DSHEA,\nNMPA TCM, BELFRIT, ANSES,\nKampo monograph"];
  quality [label="4. Quality control:\nadulteration, heavy metals,\npesticide MRLs, microbial"];
  evidence [label="5. Evidence: 30y use\n(15y EU) for THMP, or\nclinical for botanical drug"];
  label [label="6. Labeling: no disease claims,\nDSHEA disclaimer, THR mark"];
  reg [label="7. Notification / registration\nper market"];
  sell [label="8. Place on market"];
  classify -> plant -> framework -> quality -> evidence -> label -> reg -> sell;
}

EU -- Traditional Herbal Medicinal Products Directive (THMPD) 2004/24/EC

Key HMPC Monographs in Force (2026)

US -- Two Distinct Paths

Path 1: Dietary Supplement (DSHEA 1994)

Path 2: Botanical Drug (FDA Guidance 2016)

UK -- MHRA Traditional Herbal Registration (THR)

Germany -- Kommission E + AMG

France -- ANSES + Plantes Médicinales List

Italy / Belgium -- BELFRIT List

China -- TCM Regulation

Japan -- Kampo

WHO + Quality Standards

Contamination Limits

Heavy Metals (typical, EP Ch 5.20)

Pesticide Residues -- Reg 396/2005

• Default 0.01 mg/kg for non-authorized pesticides
• Plant-specific MRLs in Annex IV
• Higher tolerance for dried herbs (concentration factor up to 10x)

Microbial Limits (EP 5.1.4 / 5.1.8)

Adulteration Testing

Per-Plant Regulation Table (high-priority botanicals 2026)

MCP Integration

mcp__claude_ai_Cleo_Insight__search_signals(q="HMPC herbal monograph")
mcp__claude_ai_Cleo_Insight__search_signals(q="kratom FDA import alert")
mcp__claude_ai_Cleo_Insight__get_regulation(id) — pull Directive 2004/24, DSHEA, BELFRIT
mcp__claude_ai_CLEO_LEGAL_API__compliance/check — per-plant status check vs HMPC + BELFRIT + ANSES + DSHEA + NMPA TCM + Kampo
mcp__claude_ai_CLEO_LEGAL_API__customs/dual-use-check — CITES-listed botanicals (Hoodia, American ginseng wild, etc.)

Power This With the Cleo Legal API

Herbal medicine compliance is per-plant × per-market × per-claim. With 1,000+ commercially-used botanicals × 30+ markets × 3 claim levels (food / supplement / medicine), the matrix has 90,000+ cells. The Echinacea you sold as a supplement in 2024 moves to THMP status in 2026 in several MS. CBD novel food status changes every quarter. Kratom is unregulated federally in the US but felony in Wisconsin. The API queries the matrix.

With the Cleo Legal API at https://legaldata-public.cleolabs.co:

• GET /v2/catalog/regulations?vertical=herbal&country=EU,US,UK,DE,FR,IT,BE,CN,JP — pull THMPD, DSHEA, German Kommission E, BELFRIT, ANSES list, NMPA TCM, Kampo monographs
• POST /v2/catalog/match-product — classify the botanical product as medicine / supplement / food / cosmetic / TCM / Kampo per market — the same Ashwagandha capsule is a medicine in DE, supplement in US, restricted in DK
• POST /v2/compliance/check — batch query 50 botanicals × 8 markets in one call, returns per-plant verdict + applicable monograph + restriction
• POST /v2/webhooks?topic=hmpc_monograph,kratom,cbd,turmeric — monograph updates and per-plant restrictions move quarterly (Ashwagandha thyroid warning in 2023, Italian curcumin restriction 2019, Wisconsin kratom 2025…)
• GET /v2/search?type=signal&q=hepatotoxic+OR+adulteration — early-warning on plant-specific safety signals before they become market withdrawals

Get started:

# 1. Sign up for free at https://legaldata-public.cleolabs.co
# 2. Get your API key (3 lifetime requests free, then €349/mo for 1M)
# 3. Install the MCP server:
claude mcp add cleo-legal-api https://api.legaldata.cleolabs.co/mcp \
  --header "Authorization: Bearer ld_live_YOUR_KEY"

Tested ROI: For a botanical supplement brand with 30 SKUs × 6 markets, the API replaces ~30 hours/month of per-plant monograph + restriction lookups and catches the cross-market mismatches (CBD in Italy vs France, kratom in Wisconsin vs Tennessee) before regulators do.

Common Mistakes

• Selling supplement claims as medicine claims: "Cures" / "treats" / "prevents" = drug claim, requires NDA. Use only structure/function language under DSHEA.
• Missing 30-year evidence (EU THMP): Cannot use THMPD path without documented use ≥30 years (15 years in EU). Bibliographic evidence dossier required.
• Same product, same name, all EU: Each MS registers independently under THMPD. National registration ≠ EU-wide marketing authorization. Mutual Recognition Procedure available but not automatic.
• Pyrrolizidine alkaloid contamination: EFSA + BfArM action levels for honey + tea + supplements. Borage, comfrey, coltsfoot, butterbur — must test and exclude.
• Curcumin without hepatic warning: Italy AIFA banned curcumin-piperine supplements after 27 hepatotoxicity reports in 2019. Re-authorized 2020 with mandatory liver-function warning.
• Selling CBD as food supplement in EU pre-authorization: Novel food status since Jan 2019. Member State authorizations only with EFSA review. Italy banned synthetic CBD 2023. Verify per MS.
• Treating kratom as supplement in US federally: Not scheduled but FDA Import Alert 54-15 blocks imports. State-level bans + KCPA in 8 states change quarterly.
• Pharmacy monopoly in France: Selling any of the 540+ non-148-list medicinal plants outside pharmacy = illegal pharmacy practice. Article L4211-1 of Code de la santé publique.
• Ashwagandha without hepatic + thyroid warning: Denmark + Sweden + Norway + France issued risk assessments 2020-2024. 17 hepatotoxicity case reports. Pregnancy contraindication mandatory.